ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Income Before Tax
Profit after all operating and non-operating items but before income tax.
Income Before Tax history
Currency unavailable · from the income statement
No Income Before Tax data reported for this period type.
Income Before Tax vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -€45.61M EUR | -50.1% | — | 339.3% | |
| LTM Mar 2026 | -$48.88M USD | -44.5% | — | — | |
| FY2025 | -$76.83M USD | — | — | 412.6% | |
| LTM Mar 2026 | -$78.67M USD | -14.7% | — | 173.5% | |
| LTM Mar 2026 | -$85.16M USD | — | — | 9241.5% | |
| LTM Mar 2026 | -$120.53M USD | +28.0% | — | 151.1% | |
| LTM Mar 2026 | -$171.05M USD | -431.8% | — | 533.2% | |
| LTM Mar 2026 | -$183.59M USD | -63.4% | — | 255.7% | |
| LTM Mar 2026 | -$198.37M USD | +1.9% | — | 4917.6% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -44.5% | — | 376.0% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.